ALCRB Fundamental Analysis - CARBIOS

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ALCRB. ALCRB was compared to 69 industry peers in the Chemicals industry. While ALCRB seems to be doing ok healthwise, there are quite some concerns on its profitability. ALCRB is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALCRB had negative earnings in the past year.

ALCRB had a negative operating cash flow in the past year.

In the past 5 years ALCRB reported 4 times negative net income.

In the past 5 years ALCRB always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -11.83%, ALCRB is not doing good in the industry: 79.71% of the companies in the same industry are doing better.

The Return On Equity of ALCRB (-16.58%) is worse than 78.26% of its industry peers.

		Industry Rank	Sector Rank
ROA	-11.83%
ROE	-16.58%
ROIC	N/A

ROA(3y)-11.97%

ROA(5y)-10.26%

ROE(3y)-16.77%

ROE(5y)-14.67%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALCRB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALCRB does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALCRB has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, ALCRB has more shares outstanding

The debt/assets ratio for ALCRB has remained at the same level compared to a year ago.

2.2 Solvency

ALCRB has an Altman-Z score of 0.40. This is a bad value and indicates that ALCRB is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 0.40, ALCRB is doing worse than 82.61% of the companies in the same industry.

ALCRB has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.

ALCRB's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. ALCRB outperforms 72.46% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.18
Debt/FCF	N/A
Altman-Z	0.4

ROIC/WACCN/A

WACC7.05%

2.3 Liquidity

ALCRB has a Current Ratio of 2.79. This indicates that ALCRB is financially healthy and has no problem in meeting its short term obligations.

ALCRB's Current ratio of 2.79 is amongst the best of the industry. ALCRB outperforms 81.16% of its industry peers.

ALCRB has a Quick Ratio of 2.75. This indicates that ALCRB is financially healthy and has no problem in meeting its short term obligations.

With an excellent Quick ratio value of 2.75, ALCRB belongs to the best of the industry, outperforming 94.20% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.79
Quick Ratio	2.75

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALCRB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.76%.

ALCRB shows a strong growth in Revenue. In the last year, the Revenue has grown by 90.91%.

Measured over the past years, ALCRB shows a very negative growth in Revenue. The Revenue has been decreasing by -37.71% on average per year.

EPS 1Y (TTM)-20.76%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-30.29%

Revenue 1Y (TTM)90.91%

Revenue growth 3Y9.01%

Revenue growth 5Y-37.71%

Sales Q2Q%15.07%

3.2 Future

ALCRB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.01% yearly.

The Revenue is expected to grow by 300.17% on average over the next years. This is a very strong growth

EPS Next Y2.78%

EPS Next 2Y8.43%

EPS Next 3Y5.34%

EPS Next 5Y27.01%

Revenue Next Year108.33%

Revenue Next 2Y400%

Revenue Next 3Y452.61%

Revenue Next 5Y300.17%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCRB. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCRB. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y8.43%

EPS Next 3Y5.34%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALCRB!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CARBIOS

EPA:ALCRB (10/16/2025, 7:00:00 PM)

7.93

-0.27 (-3.23%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)09-24 2025-09-24

Earnings (Next)04-09 2026-04-09

Inst Owners17.66%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap133.62M

Analysts84

Price Target11.22 (41.49%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-5.71%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0.97%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-94.55%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	982.5
P/FCF	N/A
P/OCF	N/A
P/B	0.67
P/tB	0.85
EV/EBITDA	N/A

EPS(TTM)-2.29

EYN/A

EPS(NY)-1.86

Fwd EYN/A

FCF(TTM)-5.32

FCFYN/A

OCF(TTM)-1.79

OCFYN/A

SpS0.01

BVpS11.85

TBVpS9.36

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-11.83%
ROE	-16.58%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-11.97%

ROA(5y)-10.26%

ROE(3y)-16.77%

ROE(5y)-14.67%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.18
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	732.56%
Cap/Sales	43678.7%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.79
Quick Ratio	2.75
Altman-Z	0.4

F-Score4

WACC7.05%

ROIC/WACCN/A

Cap/Depr(3y)437.01%

Cap/Depr(5y)449.88%

Cap/Sales(3y)53289.6%

Cap/Sales(5y)34828.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-20.76%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-30.29%

EPS Next Y2.78%

EPS Next 2Y8.43%

EPS Next 3Y5.34%

EPS Next 5Y27.01%

Revenue 1Y (TTM)90.91%

Revenue growth 3Y9.01%

Revenue growth 5Y-37.71%

Sales Q2Q%15.07%

Revenue Next Year108.33%

Revenue Next 2Y400%

Revenue Next 3Y452.61%

Revenue Next 5Y300.17%

EBIT growth 1Y-29.88%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year34.55%

EBIT Next 3Y15.43%

EBIT Next 5Y34.22%

FCF growth 1Y-91.04%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-33.67%

OCF growth 3YN/A

OCF growth 5YN/A

CARBIOS (ALCRB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens